Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glyburide for severe traumatic brain injury
ChiCTR2000033637Phase 4Not yet recruiting
- Sponsor
- Department of Neurosurgery, Nanfang Hospital, Southern Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of glibenclamide in traumatic brain injury (TBI) (2 arms), sponsored by Department of Neurosurgery, Nanfang Hospital, Southern Medical University. Primary endpoint: GOSE scores. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
glibenclamide
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2000033637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033637.